Overview

A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This study is to assess if DU176b is effective in prevention of blood clots following hip replacement surgery. The duration is 7-10 days of treatment and 30 and 60 day follow-up visits.
Phase:
Phase 2
Details
Lead Sponsor:
Daiichi Sankyo Inc.
Daiichi Sankyo, Inc.
Treatments:
Edoxaban
Factor Xa Inhibitors